XLH Patient Meeting Showcases Value Of Post-Approval Feedback To US FDA
Executive Summary
X-Linked Hypophosphatemia patient feedback meeting follows recent approval of Ultragenyx’ Crysvita. Like an SMA meeting in 2017, it showed how post-approval meetings can help sustain momentum in a new class.